Home > Products > CD3 & PD1
> Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Tandem scFv)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Tandem scFv) (CAT#: BSFV-098)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD3 antibody variable domains fused with a scFv from an anti-PD1 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Tandem scFv) (BSFV-098). Click the button below to contact us or submit your feedback about this product.